Print page

Fill & Finish Resource Center

Taking the Plunge to Harmonize Pharmaceutical Regulations
Within the past five years, more of world's regulatory agencies and pharmacopeias have gotten on the same wavelength.

Getting More Scientific About Tableting
Last month brought news of resources and newer techniques being brought to bear on tableting.

A Business Case for Isolation Technology
Every sterile facility is unique, but a recent Jacobs study suggests that advanced isolation technology pays dividends in the long run.

Putting Particulates on the Map
Contamination mapping isn’t exactly cartography, but it can be an effective troubleshooting tool.

More Articles »

White Papers: In Depth Research

Cartridge Filtration in the Production of Pharma Grade Water
Posted: 07/26/2010
Cartridge filtration can be a reliable, efficient means of producing bulk pharmaceutical grade water. This detailed paper from 3M illustrates its effective use for some of the most critical applications: the removal of particulates that might contaminate water systems, eliminating Pseudomonades and other microorganisms, reducing endotoxins, and protection of storage tanks during draw-down.

Increasing Tablet Press Productivity Using Segmented Turret Technology
Author: Fette America
Posted: 04/15/2010
Surveys of tablet press users reveal that machines with segmented turrets increase output and reduce set-up and cleaning time over conventional presses and previous turret technologies. This paper will discuss survey data from drug manufacturers using the technology and quantify some of the benefits over conventional press technologies.

Where and What to Test: From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
Author: Microtest
Posted: 03/19/2009
This white paper focuses on what many consider the most critical part of a biological drug product’s manufacturing life cycle: going from the purified bulk drug substance (“PBDS”) to the sterile final drug product (“FDP”). Specifically, the white paper discusses establishing the testing “where and when” (and in some instances the “why”) for manufacturing formulation and fill/finish activities and how the approach is also applicable, for the most part, to small molecule drug products formulation and fill/finish.

SAP Support of the Healthcare Supply Chain’s Ongoing Effort to Ensure Patient Safety and Drive Business Value
Author: SAP
Posted: 12/05/2008
This white paper provides a detailed look at SAP’s support for the Center for Healthcare Supply Chain Research Blueprint for Data Management & Data Sharing. It also offers a summary of the Blueprint concepts and a review short- and long-term business improvement opportunities that can be gained by leveraging EPCIS.

More White Papers »